Jackson Creek Investment Advisors LLC Boosts Holdings in Encompass Health Co. (NYSE:EHC)

Jackson Creek Investment Advisors LLC lifted its stake in shares of Encompass Health Co. (NYSE:EHC) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,987 shares of the company’s stock after acquiring an additional 484 shares during the period. Jackson Creek Investment Advisors LLC’s holdings in Encompass Health were worth $1,107,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. CIBC Asset Management Inc increased its stake in Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after acquiring an additional 100 shares during the last quarter. Miracle Mile Advisors LLC raised its stake in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after acquiring an additional 112 shares during the period. US Bancorp DE lifted its holdings in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after acquiring an additional 121 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its position in Encompass Health by 87.8% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after purchasing an additional 137 shares during the period. Finally, SPC Financial Inc. increased its holdings in Encompass Health by 0.3% in the 4th quarter. SPC Financial Inc. now owns 45,077 shares of the company’s stock valued at $4,163,000 after purchasing an additional 154 shares in the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Wall Street Analysts Forecast Growth

EHC has been the topic of a number of recent research reports. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. KeyCorp increased their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, Barclays raised their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $107.67.

Encompass Health Price Performance

Shares of EHC stock opened at $99.20 on Friday. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm has a market cap of $9.99 billion, a P/E ratio of 22.24, a P/E/G ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 1-year low of $74.27 and a 1-year high of $104.55. The firm has a fifty day moving average of $96.84 and a two-hundred day moving average of $96.61.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.